South Africa’s healthcare sector is shifting from reactive treatment to a more predictive, data-driven model of care underpinned by artificial intelligence-assisted diagnostics, interoperable digital patient records and connected medical devices. But the pace and safety of that shift hinge not on technology alone: clinical value, integration into care pathways and regulatory compliance will determine whether innovations are adopted widely.
WHX 2026 to focus on clinical value and governance
The World Health Expo (WHX) 2026, formerly Africa Health, will return to Johannesburg from 6–8 October. The event will convene healthcare providers, laboratory and diagnostic professionals, technology suppliers, policymakers, investors, distributors and regulatory stakeholders from South Africa, the Southern African Development Community (SADC) and international markets.
Alongside a commercial exhibition, WHX will host three specialist indabas that aim to interrogate the operational, clinical and commercial issues shaping healthcare on the continent. The programme will place particular emphasis on modernising hospital infrastructure, global health priorities and the ethical governance of health technology decisions.
From proof-of-concept to bedside: the barriers
Speakers and organisers say that for AI and related digital tools to transform care they must:
- demonstrate clear clinical value in real-world settings;
- integrate safely and seamlessly into existing care pathways;
- meet the regulatory requirements that govern their use in patient care.
Those three requirements form the core of discussions planned at WHX 2026, reflecting concerns that technology which looks promising in the lab does not always translate into improved patient outcomes when deployed at scale.
“AI and related innovations offer significant opportunities to improve health in Africa and globally, but their adoption must maximise benefits while preventing avoidable harm,”
said Professor Edward Kunonga, Chair of the Healthcare Excellence Indaba and Strategic Advisor, Global Health, Durham, United Kingdom. He added that technologies require local validation on South African and African patient populations and testing within real health systems with clear accountability and meaningful human oversight.
What the technical and regulatory conversation will cover
Delegates at the healthcare-focused forums will tackle a range of topics where technology and policy intersect, including:
- how hospitals can modernise infrastructure to support connected medical devices and digital records;
- ethical governance and accountability frameworks for AI-assisted clinical tools;
- pathways for local clinical validation to ensure algorithms work for South African populations;
- commercial models that balance innovation incentives with patient safety.
The emphasis on local validation and oversight recognises that algorithms trained on non-representative datasets can underperform or introduce bias when applied to different populations. That problem is especially acute in diverse health systems where disease profiles, genetic backgrounds and care pathways differ.
| Event | When | Where | Focus |
|---|---|---|---|
| WHX 2026 | 6–8 October | Johannesburg | AI diagnostics, interoperable records, devices, policy and commercialisation |
As South African hospitals and clinics consider investment in digital tools, procurement and regulatory processes will play a decisive role. Technologies that cannot demonstrate clinical benefit or that struggle to integrate with electronic health records risk being sidelined, regardless of their promise in controlled studies.
For policy-makers and health leaders, the challenge is to create a regulatory and operational environment that supports innovation while protecting patients. That includes insisting on meaningful human oversight of algorithmic decisions, transparent validation studies on local populations, and careful pilots inside functioning care systems before wider rollout.
The conversations at WHX 2026 will therefore matter beyond the halls of the expo: they will shape how and how quickly AI-assisted diagnostics, connected devices and interoperable records appear in South African clinics and hospitals — and whether they improve outcomes for patients.
